To Get More Information on Deep Brain Stimulation (DBS) Devices Market - Request Sample Report
The Deep Brain Stimulation (DBS) Devices Market Size was valued at USD 1.25 billion in 2023 and is witnessed to reach USD 3.10 billion by 2032 and grow at a CAGR of 11.12% over the forecast period 2024-2032.
The high mortality and disease burden, coupled with the lack of effective pharmacotherapies necessitates the development and utilization of long-term solutions such as deep brain stimulation. In addition, the rising interest in large neurological disease burden has triggered demand for deep brain stimulators as a substitute therapy.
Also, technological improvements in deep brain stimulation devices are expected to offer lucrative growth opportunities. Examples of these technological advances include multi-target stimulation, robotic implantation-assistance systems microelectrode designs, rechargeable implantable pulse generators, as well as personalized directed programming. For example, in July 2022 Abbott announced FDA Breakthrough Device Designation for its deep brain stimulation system. The designation is awarded to study the use of the DBS system for treatment-resistant depression, an advanced manifestation of major depressive disorder.
This recognition highlights the significance of Abbott's novel path to helping patients with a challenging and serious medical condition, advancing the opportunities for breakthroughs in depression treatment. The occurrence of mobility and psychiatric conditions is very high in the aging population, particularly in countries such as the U.S., and Canada where the geriatric prevalence is increasing rapidly. Symptoms of Parkinson's Disease, for example, occur typically around the age of 60 on average (Parkinson's Foundation). The elderly population suffers from these disorders the most. Likewise, the Canadian Psychological Association reports that 2% of Canadians have obsessive-compulsive disorder.
All, these factors are skyrocketing the growth of the deep brain stimulation devices market growth.
.MARKET DYNAMICS:
KEY DRIVERS:
RESTRAINTS:
OPPORTUNITY:
By Product
Product-wise the market is divided into single-channel and dual-channel DBS devices. With a 58% market share in 2023, the dual-channel segment had dominated due to its widespread application across various surgical procedures. Dual-channel devices are among the safest and most effective-in-use tools used in surgical procedures. As a result, the burgeoning occurrence rate of disabling neurological diseases, the mounting need for surgeries related to Parkinson's disease (PD), and the mushrooming number of hospitals exchanging single-channel deep brain stimulation (DBS) devices with dual-channel ones anticipating advantages such as elevated treatment outcomes are some crucial factors aiding in favoring growth trajectory across this segment. In addition, the continued advancements in technology and new product offerings are driving growth within this sector. Single-channel DBS Devices are expected to witness the highest growth rate from 2023 to 2030.
By Application
Factors such as the application; the Parkinson's disease accounted for a 66.01 % share in 2023. The growth is credited to a surge in the rate of approvals by the U.S. FDA for deep brain stimulation therapy, the high prevalence of Parkinson's Disease internationally, and enhanced research & development activities. In March 2023, for example, a team at Michigan Technological University reported using neuromorphic computing to increase the efficiency by which deep brain stimulation (DBS) improves Parkinson's disease. The new model could lead this whole category to step-change growth in the future.
By End-Use
Overall, the market was led by the hospital end-use segment accounting for a share of 52% in 2023. In hospital settings and with the increasing prevalence of Parkinson's disease, essential tremor is expected to expand more rapidly due in large part to hospitals & growing number will materialize during complex surgeries for medication-resistant treatment upsurge. Furthermore, the demand for technologically advanced DBS devices along with encouraging reimbursement policies is expected to drive significant growth in this segment over the forecast years. Medtronic is a prime illustrative example of providing comprehensive services for ensuring ongoing coverage, as well as ease of payment with DBS (of any variety) across the spectrum.
Do You Need any Customization Research on Deep Brain Stimulation (DBS) Devices Market - Enquire Now
REGIONAL COVERAGE:
REGIONAL ANALYSES
In 2023, the market is dominated by North America holding a share of 52.3% due to an increase in government funding and initiatives taken to create awareness about Parkinson's disease will drive demand for deep brain stimulator devices Additionally, the market growth in this region is driven by the presence of key players along with availability of advanced healthcare infrastructure and favorable government initiatives. The National Institute of Neurological Disorders and Stroke, for example, funds research activities aimed at assessing both the safety and efficacy of deep brain stimulation devices used in treating Parkinson's disease.
Additionally, the Asia Pacific is projected to grow passively during the projected timeframe. It is because of the increasing prevalence rate for neurodegenerative disorders which may result in increased demand for advanced and long-term treatments. Moreover, increasing patient base coupled with rising awareness regarding the availability of treatment for neurological disease and advances in the clinical development environment within developing countries is anticipated to boost deep brain stimulation devices market growth over the forecast period. In addition, the availability of lucrative growth opportunities in emerging economies such as Japan India, and China among others is expected to drive the deep brain stimulation devices market. Rise in the establishment of organizations such as the Asia Pacific Centre for Neuromodulation which is found in Tugun Australia to research and create awareness regarding DBS, this will support deep brain stimulation devices market growth.
The deep brain stimulation devices market players include Abbott Laboratories, Beijing Pinchi Medical Equipment Co., Ltd., Boston Scientific Corporation, Fisher Wallace Laboratories, Functional Neuromodulation Ltd., Medtronic, NeuroPace Inc., Renishaw PLC, Aleva Neurotherapeutics S.A. & LivaNova PLC & Other Players.
RECENT DEVELOPMENTS
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.25 Billion |
| Market Size by 2032 | US$ 3.10 Billion |
| CAGR | CAGR of 11.12% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Single-channel, Dual-channel) •By Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease & Others) •By End-use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers & Research Centers) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, Beijing Pinchi Medical Equipment Co., Ltd., Boston Scientific Corporation, Fisher Wallace Laboratories, Functional Neuromodulation Ltd., Medtronic, NeuroPace Inc., Renishaw PLC, Aleva Neurotherapeutics S.A. & LivaNova PLC & Other Players |
| Key Drivers | •Rapidly Aging Population is responsible for rising neurological disorders which is Generating the Need for Deep Brain Stimulation Devices •Surging Demand for Deep Brain Stimulation Devices because of the Rising Popularity of Minimally Invasive Procedures. |
| RESTRAINTS | •Complications regarding Deep Brain Stimulation Procedures are Hindering the Growth of the Market. •Implementing Stringent Government Policies Can Limit the Adoption of Deep Brain Stimulation (DBS) Devices. |
Ans: The Deep Brain Stimulation (DBS) Devices Market is expected to grow at 11.12% CAGR from 2024 to 2032.
Ans: The Deep Brain Stimulation (DBS) Devices Market is anticipated to reach USD 3.10 billion by 2032.
Ans: The prevalence of neurological illnesses is rising, people want a tailored approach, and technical improvements are major growth drivers for the deep brain stimulation device market.
Ans: TThe deep brain stimulation devices market players include Abbott Laboratories, Beijing Pinchi Medical Equipment Co., Ltd., Boston Scientific Corporation, Fisher Wallace Laboratories, Functional Neuromodulation Ltd., Medtronic, NeuroPace Inc., Renishaw PLC, Aleva Neurotherapeutics S.A. & LivaNova PLC & Other Players.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Deep Brain Stimulation (DBS) Devices Market Segmentation, By Product
7.1 Introduction
7.2 Single Channel
7.3 Dual Channel
8. Deep Brain Stimulation (DBS) Devices Market Segmentation, By Application
8.1 Introduction
8.2 Pain Management
8.3 Epilepsy
8.4 Essential Tremor
8.5 Obsessive Compulsive Disorder (OCD)
8.6 Depression
8.7 Dystonia
8.8 Parkinson’s Disease
8.9 Others
9. Deep Brain Stimulation (DBS) Devices Market Segmentation, By End-Use
9.1 Introduction
9.2 Hospitals
9.3 Neurology Clinics
9.4 Ambulatory Surgical Centers
9.5 Research Centers
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 Trend Analysis
10.2.2 North America Deep Brain Stimulation (DBS) Devices Market by Country
10.2.3 North America Deep Brain Stimulation (DBS) Devices Market By Product
10.2.4 North America Deep Brain Stimulation (DBS) Devices Market By Application
10.2.5 North America Deep Brain Stimulation (DBS) Devices Market By End-Use
10.2.6 USA
10.2.6.1 USA Deep Brain Stimulation (DBS) Devices Market By Product
10.2.6.2 USA Deep Brain Stimulation (DBS) Devices Market By Application
10.2.6.3 USA Deep Brain Stimulation (DBS) Devices Market By End-Use
10.2.7 Canada
10.2.7.1 Canada Deep Brain Stimulation (DBS) Devices Market By Product
10.2.7.2 Canada Deep Brain Stimulation (DBS) Devices Market By Application
10.2.7.3 Canada Deep Brain Stimulation (DBS) Devices Market By End-Use
10.2.8 Mexico
10.2.8.1 Mexico Deep Brain Stimulation (DBS) Devices Market By Product
10.2.8.2 Mexico Deep Brain Stimulation (DBS) Devices Market By Application
10.2.8.3 Mexico Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3 Europe
10.3.1 Trend Analysis
10.3.2 Eastern Europe
10.3.2.1 Eastern Europe Deep Brain Stimulation (DBS) Devices Market by Country
10.3.2.2 Eastern Europe Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.3 Eastern Europe Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.4 Eastern Europe Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.2.5 Poland
10.3.2.5.1 Poland Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.5.2 Poland Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.5.3 Poland Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.2.6 Romania
10.3.2.6.1 Romania Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.6.2 Romania Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.6.4 Romania Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.2.7 Hungary
10.3.2.7.1 Hungary Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.7.2 Hungary Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.7.3 Hungary Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.2.8 Turkey
10.3.2.8.1 Turkey Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.8.2 Turkey Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.8.3 Turkey Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.2.9 Rest of Eastern Europe
10.3.2.9.1 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market By Product
10.3.2.9.2 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market By Application
10.3.2.9.3 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3 Western Europe
10.3.3.1 Western Europe Deep Brain Stimulation (DBS) Devices Market by Country
10.3.3.2 Western Europe Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.3 Western Europe Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.4 Western Europe Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.5 Germany
10.3.3.5.1 Germany Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.5.2 Germany Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.5.3 Germany Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.6 France
10.3.3.6.1 France Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.6.2 France Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.6.3 France Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.7 UK
10.3.3.7.1 UK Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.7.2 UK Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.7.3 UK Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.8 Italy
10.3.3.8.1 Italy Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.8.2 Italy Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.8.3 Italy Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.9 Spain
10.3.3.9.1 Spain Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.9.2 Spain Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.9.3 Spain Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.10 Netherlands
10.3.3.10.1 Netherlands Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.10.2 Netherlands Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.10.3 Netherlands Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.11 Switzerland
10.3.3.11.1 Switzerland Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.11.2 Switzerland Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.11.3 Switzerland Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.12 Austria
10.3.3.12.1 Austria Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.12.2 Austria Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.12.3 Austria Deep Brain Stimulation (DBS) Devices Market By End-Use
10.3.3.13 Rest of Western Europe
10.3.3.13.1 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market By Product
10.3.3.13.2 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market By Application
10.3.3.13.3 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4 Asia-Pacific
10.4.1 Trend Analysis
10.4.2 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by Country
10.4.3 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By Product
10.4.4 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By Application
10.4.5 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.6 China
10.4.6.1 China Deep Brain Stimulation (DBS) Devices Market By Product
10.4.6.2 China Deep Brain Stimulation (DBS) Devices Market By Application
10.4.6.3 China Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.7 India
10.4.7.1 India Deep Brain Stimulation (DBS) Devices Market By Product
10.4.7.2 India Deep Brain Stimulation (DBS) Devices Market By Application
10.4.7.3 India Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.8 Japan
10.4.8.1 Japan Deep Brain Stimulation (DBS) Devices Market By Product
10.4.8.2 Japan Deep Brain Stimulation (DBS) Devices Market By Application
10.4.8.3 Japan Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.9 South Korea
10.4.9.1 South Korea Deep Brain Stimulation (DBS) Devices Market By Product
10.4.9.2 South Korea Deep Brain Stimulation (DBS) Devices Market By Application
10.4.9.3 South Korea Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.10 Vietnam
10.4.10.1 Vietnam Deep Brain Stimulation (DBS) Devices Market By Product
10.4.10.2 Vietnam Deep Brain Stimulation (DBS) Devices Market By Application
10.4.10.3 Vietnam Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.11 Singapore
10.4.11.1 Singapore Deep Brain Stimulation (DBS) Devices Market By Product
10.4.11.2 Singapore Deep Brain Stimulation (DBS) Devices Market By Application
10.4.11.3 Singapore Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.12 Australia
10.4.12.1 Australia Deep Brain Stimulation (DBS) Devices Market By Product
10.4.12.2 Australia Deep Brain Stimulation (DBS) Devices Market By Application
10.4.12.3 Australia Deep Brain Stimulation (DBS) Devices Market By End-Use
10.4.13 Rest of Asia-Pacific
10.4.13.1 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By Product
10.4.13.2 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By Application
10.4.13.3 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5 Middle East & Africa
10.5.1 Trend Analysis
10.5.2 Middle East
10.5.2.1 Middle East Deep Brain Stimulation (DBS) Devices Market by Country
10.5.2.2 Middle East Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.3 Middle East Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.4 Middle East Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.2.5 UAE
10.5.2.5.1 UAE Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.5.2 UAE Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.5.3 UAE Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.2.6 Egypt
10.5.2.6.1 Egypt Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.6.2 Egypt Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.6.3 Egypt Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.2.7 Saudi Arabia
10.5.2.7.1 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.7.2 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.7.3 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.2.8 Qatar
10.5.2.8.1 Qatar Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.8.2 Qatar Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.8.3 Qatar Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.2.9 Rest of Middle East
10.5.2.9.1 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market By Product
10.5.2.9.2 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market By Application
10.5.2.9.3 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.3 Africa
10.5.3.1 Africa Deep Brain Stimulation (DBS) Devices Market by Country
10.5.3.2 Africa Deep Brain Stimulation (DBS) Devices Market By Product
10.5.3.3 Africa Deep Brain Stimulation (DBS) Devices Market By Application
10.5.3.4 Africa Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.3.5 Nigeria
10.5.3.5.1 Nigeria Deep Brain Stimulation (DBS) Devices Market By Product
10.5.3.5.2 Nigeria Deep Brain Stimulation (DBS) Devices Market By Application
10.5.3.5.3 Nigeria Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.3.6 South Africa
10.5.3.6.1 South Africa Deep Brain Stimulation (DBS) Devices Market By Product
10.5.3.6.2 South Africa Deep Brain Stimulation (DBS) Devices Market By Application
10.5.3.6.3 South Africa Deep Brain Stimulation (DBS) Devices Market By End-Use
10.5.3.7 Rest of Africa
10.5.3.7.1 Rest of Africa Deep Brain Stimulation (DBS) Devices Market By Product
10.5.3.7.2 Rest of Africa Deep Brain Stimulation (DBS) Devices Market By Application
10.5.3.7.3 Rest of Africa Deep Brain Stimulation (DBS) Devices Market By End-Use
10.6 Latin America
10.6.1 Trend Analysis
10.6.2 Latin America Deep Brain Stimulation (DBS) Devices Market by country
10.6.3 Latin America Deep Brain Stimulation (DBS) Devices Market By Product
10.6.4 Latin America Deep Brain Stimulation (DBS) Devices Market By Application
10.6.5 Latin America Deep Brain Stimulation (DBS) Devices Market By End-Use
10.6.6 Brazil
10.6.6.1 Brazil Deep Brain Stimulation (DBS) Devices Market By Product
10.6.6.2 Brazil Deep Brain Stimulation (DBS) Devices Market By Application
10.6.6.3 Brazil Deep Brain Stimulation (DBS) Devices Market By End-Use
10.6.7 Argentina
10.6.7.1 Argentina Deep Brain Stimulation (DBS) Devices Market By Product
10.6.7.2 Argentina Deep Brain Stimulation (DBS) Devices Market By Application
10.6.7.3 Argentina Deep Brain Stimulation (DBS) Devices Market By End-Use
10.6.8 Colombia
10.6.8.1 Colombia Deep Brain Stimulation (DBS) Devices Market By Product
10.6.8.2 Colombia Deep Brain Stimulation (DBS) Devices Market By Application
10.6.8.3 Colombia Deep Brain Stimulation (DBS) Devices Market By End-Use
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market By Product
10.6.9.2 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market By Application
10.6.9.3 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market By End-Use
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 The SNS View
11.2 Beijing Pinchi Medical Equipment Co., Ltd.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 The SNS View
11.3 Boston Scientific Corporation
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 The SNS View
11.4 Fisher Wallace Laboratories
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 The SNS View
11.5 Functional Neuromodulation Ltd.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 The SNS View
11.6 Medtronic
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 The SNS View
11.7 NeuroPace Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 The SNS View
11.8 Renishaw PLC
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 The SNS View
11.9 Aleva Neurotherapeutics S.A.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 The SNS View
11.10 LivaNova PLC
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. Use Case and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Computer Vision in Healthcare Market Size was valued at USD 1.46 billion in 2023, and is expected to reach USD 33.32 billion by 2031, and grow at a CAGR of 47.8% over the forecast period 2024-2031.
The Needle-Free Injector Market size was valued at USD 1.87 billion in 2023 and is expected to reach USD 3.37 billion by 2031 with a growing CAGR of 7.59% over the forecast period of 2024-2031.
The Healthcare Analytical Testing Services Market Size was valued at USD 14.1 billion in 2023, and is expected to reach USD 26.88 billion by 2031, and grow at a CAGR of 8.4% over the forecast period 2024-2031.
The Dermatology Drugs Market size was USD 41.67 Billion in 2023 and is expected to Reach USD 78.86 Billion by 2031 and grow at a CAGR of 8.3% over the forecast period of 2024-2031.
The Cystic Fibrosis Market size was valued at US$ 6.02 Billion in 2023 and is estimated to reach US$ 18.66 Billion by 2032 with a growing CAGR of 13.4% Over the Forecast Period 2024-2032.
The Cell Banking Outsourcing Market Size was valued at USD 12.5 billion in 2023 and is projected to reach USD 41.54 Billion by 2031 with a growing CAGR of 16.2% Over the Forecast Period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
